Skye Bioscience Inc. (SKYE)
SKYE trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.53
-3.17% on the day
Market cap
$6.8M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | SKYE on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0001516551 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | NV |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B3 | 2024-05-17 |
| Latest annual report | 10-K | 2026-03-10 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K | 2026-09-11 |
| Latest proxy | DEFA14A | 2026-09-11 |
Source: SEC EDGAR submissions feed, 628 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| LGVN | Longeveron Inc. | $2.15 | -12.24% | $6.9M |
| ACXP | Acurx Pharmaceuticals Inc. | $1.20 | -6.25% | $6.7M |
| NRSN | NeuroSense Therapeutics Ltd. | $3.49 | +0.29% | $6.6M |
| ALZN | Alzamend Neuro Inc. | $1.35 | +3.05% | $6.5M |
| FBLG | FibroBiologics Inc. | $0.9599 | -4.01% | $6.5M |
| APUS | Apimeds Pharmaceuticals US Inc. | $4.62 | -11.15% | $7.1M |
| TRAW | Traws Pharma Inc. | $0.4101 | -1.42% | $6.3M |
| SNGX | Soligenix Inc. | $0.3348 | -4.80% | $7.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier